Laura Shawver is of Silverback Therapeutics, Inc.. Currently has a direct ownership of 210,346 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 08, 2023, when has been sold 57,100 shares (Common Stock) at a price of $1.27 per share, resulting in proceeds of $72,517. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
0% 12M change
Total Value Held $0

Laura Shawver Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2023
BUY
Exercise of conversion of derivative security
$72,517 $1.27 p/Share
57,100 Added 17.59%
267,446 Common Stock
Nov 09 2022
SELL
Open market or private sale
$201,043 $4.58 p/Share
43,896 Reduced 17.27%
210,346 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
$100,000 $1.27 p/Share
78,740 Added 23.65%
254,242 Common Stock
May 02 2022
BUY
Grant, award, or other acquisition
-
68,107 Added 27.96%
175,502 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
27,500 Added 20.39%
107,395 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
LS

Laura Shawver

Seattle, WA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX